Citations

Clear

4 citation(s) found for "Kies, Paige".

Novel wounded porcine skin ex vivo methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa infection models
Kies, Paige , Gades, Naomi M , Tian, Aileen , Soto, Mya L, Mandrekar, Jay , Garcia, Elijah , Patel, Robin

Mayo Clinic

Infection and Immunity | November 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1128/iai.00489-26 | PMID 43037414 Get It

ABSTRACT Chronic wounds are a growing challenge in clinical practice and can be associated with infection by antimicrobial-resistant bacteria. With increasing demand for pathophysiology research and therapeutic technology development, biologically relevant platforms like infected swine skin explants are used; however, explants are not typically studied in conjunction with normal microbiota, which recapitulates the clinical scenario. The current study generated 1- and 8-cm diameter wounded swine skin explants from shaved, sanitized swine skin harvested immediately after euthanasia. Tissue morphology was evaluated over 9 days using a custom histological grading scale and growth dynamics of skin microbiota monitored. Explant viability decreased after 3 days in association with a peak in normal microbiota of varying diversity. Stable co-colonization of wound beds with clinical Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus isolates alongside microbiota over 3 days was demonstrated. In summary, the presented 1- and 8-cm explant models maintain normal microbiota and are suitable for microbiome and/or wound infection treatment or prevention studies.
Activity of HOCl-generating e-bandage with clinically available hydrogels against Staphylococcus aureus and Acinetobacter baumannii biofilms
Dağsuyu, Eda , Kies, Paige J. , Karau, Melissa J. , Patel, Robin , Beyenal, Haluk , Kies, Paige , Patel, Robin , Beyenal, H

Mayo Clinic

Microbiology Spectrum | September 18, 2025 | Volume: 13 | Issue: 10 | Pages: No page available

10.1128/spectrum.01762-25 | PMID 40965148 Get It

ABSTRACT Biofilms hinder wound infection healing, making wound infections a healthcare challenge for which innovative treatments are needed. A 1.77 cm 2 electrochemical bandage (e-bandage), which generates the biocide hypochlorous acid (HOCl), has shown promising anti-biofilm activity in vitro , ex vivo , and in vivo . The e-bandage is a three-electrode system operationalized by a hydrogel. In addition to providing a conductive electrolyte for the electrodes, the hydrogel provides a protective barrier for the wound. How different hydrogels impact e-bandage functionality is not completely defined. Here, the in vitro activity of seven clinically available hydrogels (xanthan gum, 3M, Duoderm, Prontosan, Purilon, Skintegrity, and Solosite) was evaluated with 1.77 cm 2 HOCl-generating e-bandages using a potentiostat with a multiplexer in a membrane biofilm model against methicillin-resistant Staphylococcus aureus IDRL-6169 and Acinetobacter baumannii ATCC-17978. When applied with polarized HOCl-producing e-bandages, all evaluated hydrogels except Solosite yielded ≥5.5 log 10 CFU/cm 2 reductions in bacterial quantities after 6 h of treatment, with most being below the detection limit at that time point. Prontosan exhibited antibacterial activity independent of e-bandage. Results of this study inform the selection of clinically available hydrogels that may be suitable for use with a 1.77 cm 2 HOCl-producing e-bandage. IMPORTANCE In this study, it was shown that some clinically available hydrogels, combined with a 1.77 cm 2 HOCl-generating electrochemical bandage, deliver time-dependent antimicrobial activity against methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii biofilms, offering a potential approach to treat wound infections, including those caused by antimicrobial-resistant bacteria.
H 2 O 2 ‐Producing Electrochemical Bandages Are Active Using Off‐the‐Shelf Hydrogels
Dağsuyu, Eda , Kies, Paige J. , Patel, Robin , Beyenal, Haluk , Kies, Paige , Patel, Robin , Beyenal, H

Mayo Clinic

Wound Repair and Regeneration | September 16, 2025 | Volume: 33 | Issue: 5 | Pages: No page available

10.1111/wrr.70092 | PMID 40955068 Get It

ABSTRACT An electrochemical bandage (e‐bandage) that generates hydrogen peroxide (H 2 O 2 ) through a combination of working, counter and reference electrodes used with an electrolyte‐providing hydrogel is being developed for wound infection management. e‐Bandage biocidal activity was previously demonstrated using Xanthan gum hydrogel. For clinical use, clinically used hydrogels would be ideal, but their use with the described e‐bandage has not been shown. The goal of this work was to evaluate the biocidal activity of off‐the‐shelf, clinically used hydrogels when used with a 1.77 cm 2 H 2 O 2 ‐producing e‐bandage. e‐Bandage electrochemical parameters and activity against methicillin‐resistant Staphylococcus aureus IDRL‐6169 and Acinetobacter baumannii ATCC‐17978 biofilms were assessed with six off‐the‐shelf hydrogels. Variations in hydrogel composition affected electrochemical parameters, which was associated with differences in biocidal activity. Results of this study inform the selection of off‐the‐shelf hydrogels for use with H 2 O 2 ‐producing e‐bandages.
P-1091. Hydrogen peroxide generating electrochemical bandage for the treatment of wound biofilm infections - preliminary demonstration of device safety on healthy human skin
Kim, Won‐Jun , Anoy, Md Monzurul Islam , Bozyel, Ibrahim , Holtegaard, Susan, Greenwood‐Quaintance, Kerryl E. , Kies, Paige J. , Fleming, Derek , Beyenal, Haluk , Patel, Robin

Mayo Clinic

Open Forum Infectious Diseases | January 29, 2025 | Volume: 12 | Issue: Supplement_1 | Pages: No page available

10.1093/ofid/ofae631.1279 Get It

Abstract Background Wound biofilm infections impact ∼2% of the United States and at-risk individuals often have underlying morbidities such as diabetes. Antibiotics and topical approaches like debridement or silver dressings have had limited success, underscoring a need for strategies that efficiently target pathogens in wound beds. Methods We developed a hydrogen peroxide (H2O2) generating electrochemical bandage (e-bandage) composed of carbon fabric electrodes separated by cotton fabric with an Ag/AgCl reference electrode (RE) placed between cotton fabric layers. The e-bandage is controlled by a wearable micropotentiostat (MP); H2O2 is generated by O2 + 2H++ 2e- → H2O2. O2 is dissolved on a primary working electrode with negative polarity compared to the RE while a positively polarized secondary counter electrode generates H+ and e-. The H2O2 e-bandage/MP device has in vitro activity against mono- and dual-species bacterial and fungal biofilms. We showed that the H2O2 e-bandage decreased the burden of methicillin-resistant Staphylococcus aureus and/or Pseudomonas aeruginosa with difficult-to-treat resistance in a murine wound infection model. Given this, we initiated a H2O2 e-bandage safety assessment on healthy human skin. Here, testing of a non-polarized, circular (2 cm diameter) device pre-loaded with biocompatible hydrogel containing 0.9% NaCl is reported. Sterilized e-bandages assessed in a shelf-life study retained activity for two weeks. Adults with intact forearm skin were then recruited to the Clinical Research Trials Unit at the Mayo Clinic. Consented individuals had a non-polarized e-bandage covered by Tegaderm placed on their forearm. A MP enclosed in a biocompatible case was connected to the e-bandage and secured using skin tape. One day later, the device was removed and a follow-up phone call made six days later to assess for adverse effects. Results Three volunteers wearing a non-polarized H2O2 e-bandage experienced no discomfort, irritation, allergic reaction, or skin discoloration after device removal and seven days post device placement. Conclusion These preliminary studies combined with the previously performed murine bacterial biofilms work support further studies of this novel device for treating wound infections caused by antimicrobial resistant pathogens. Disclosures Robin Patel, MD, a patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, a: See above|MicuRx Pharmaceuticals and BIOFIRE: Grant/Research Support|PhAST, Day Zero Diagnostics, Abbott Laboratories, Sysmex, DEEPULL DIAGNOSTICS, S.L., Netflix, Oxford Nanopore Technologies and CARB-X: Advisor/Consultant|Up-to-Date and the Infectious Diseases Board Review Course.: Honoraria